摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-溴-2-(吡咯烷-1-基)嘧啶 | 446286-61-9

中文名称
5-溴-2-(吡咯烷-1-基)嘧啶
中文别名
——
英文名称
5-bromo-2-(pyrrolidin-1-yl)pyrimidine
英文别名
5-bromo-2-pyrrolidin-1-ylpyrimidine
5-溴-2-(吡咯烷-1-基)嘧啶化学式
CAS
446286-61-9
化学式
C8H10BrN3
mdl
MFCD00483243
分子量
228.091
InChiKey
AKQGPROZPHKDMD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    345.0±34.0 °C(Predicted)
  • 密度:
    1.555±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    29
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险品标志:
    Xn,Xi
  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:9ca81402883e15afdcf444cf37e2b8f7
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 5-Bromo-2-pyrrolidinopyrimidine
Synonyms: 5-Bromo-2-(pyrrolidin-1-yl)pyrimidine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-pyrrolidinopyrimidine
CAS number: 446286-61-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10BrN3
Molecular weight: 228.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    5-溴-2-(吡咯烷-1-基)嘧啶 在 nickel(II) acetylacetonate dihydrate 、 2,9-二甲基-4,7二苯基-1,10-菲啰啉magnesium1,2-二溴乙烷lithium chloride 、 magnesium chloride 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 反应 15.08h, 生成 C16H20N6
    参考文献:
    名称:
    环丙烷环作为 Ni 催化的 C(sp3)-O 芳基化反应的自由基离去基团反应的报告分子
    摘要:
    理解和预测反应性的能力对于新反应的发展非常重要。在 Ni 催化的 C(sp3)-O 官能化的背景下,我们开发了一种独特的策略,采用活化的环丙醇来帮助设计和优化用于 C(sp3)-O 芳基化的氧化还原活性离去基团。在该化学中,环丙烷环充当离去基团反应性的报告分子,因为在极性 (2e) 条件下获得开环产物,而在自由基 (1e) 条件下获得闭环产物。机理研究表明,最佳离去基团具有氧化还原活性,并且与 Ni(I)/Ni(III) 催化循环一致。优化的反应条件还用于合成许多芳基环丙烷,它们是有价值的药物基序。
    DOI:
    10.1021/jacs.0c06904
  • 作为产物:
    描述:
    四氢吡咯5-溴-2-氯嘧啶potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 16.0h, 以88%的产率得到5-溴-2-(吡咯烷-1-基)嘧啶
    参考文献:
    名称:
    环丙烷环作为 Ni 催化的 C(sp3)-O 芳基化反应的自由基离去基团反应的报告分子
    摘要:
    理解和预测反应性的能力对于新反应的发展非常重要。在 Ni 催化的 C(sp3)-O 官能化的背景下,我们开发了一种独特的策略,采用活化的环丙醇来帮助设计和优化用于 C(sp3)-O 芳基化的氧化还原活性离去基团。在该化学中,环丙烷环充当离去基团反应性的报告分子,因为在极性 (2e) 条件下获得开环产物,而在自由基 (1e) 条件下获得闭环产物。机理研究表明,最佳离去基团具有氧化还原活性,并且与 Ni(I)/Ni(III) 催化循环一致。优化的反应条件还用于合成许多芳基环丙烷,它们是有价值的药物基序。
    DOI:
    10.1021/jacs.0c06904
点击查看最新优质反应信息

文献信息

  • [EN] AZETIDIN-3-YLMETHANOL DERIVATIVES AS CCR6 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'AZÉTIDIN-3-YLMÉTHANOL EN TANT QUE MODULATEURS DU RÉCEPTEUR CCR6
    申请人:IDORSIA PHARMACEUTICALS LTD
    公开号:WO2021219849A1
    公开(公告)日:2021-11-04
    The present invention relates to compounds of Formula (I), their synthesis and use as CCR6 receptor modulators for the treatment or prevention of various diseases, conditions or disorders.
    本发明涉及式(I)化合物,其合成以及作为CCR6受体调节剂用于治疗或预防各种疾病、状况或障碍。
  • [EN] BICYCLIC COMPOUND AND USE THEREOF FOR INHIBITING SUV39H2<br/>[FR] COMPOSÉ BICYCLIQUE ET SON UTILISATION POUR INHIBER SUV39H2
    申请人:ONCOTHERAPY SCIENCE INC
    公开号:WO2017058503A1
    公开(公告)日:2017-04-06
    The present invention directs to a compound represented by formula (I).
    本发明涉及一种由化学式(I)表示的化合物。
  • [EN] PYRAZOLIDIN-3-ONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRAZOLIDINE-3-ONE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2012146552A1
    公开(公告)日:2012-11-01
    The present invention relates to ethynyl derivatives of formula I wherein X is N or CH; G is N or CH; with the proviso that maximum one of X or G can be nitrogen; R1 is phenyl or pyridyl, which are optionally substituted by halogen, lower alkyl or lower alkoxy; R2 is hydrogen, lower alkyl or may form together with R 4 a C3-C6-cycloalkyl; R3/R3'/R4/R4' are independently from each other hydrogen, lower alkyl or CF3; or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. It has now surprisingly been found that the compounds of general formula I are positive allosteric modulators (PAM) of the metabotropic glutamate receptor subtype 5 (mGluR5).
    本发明涉及公式I的乙炔生物,其中X为N或CH;G为N或CH;但X或G中最多只能有一个是氮;R1为苯基或吡啶基,可以选择地被卤素、较低烷基或较低烷氧基取代;R2为氢、较低烷基或可能与R4一起形成C3-C6环烷基;R3/R3'/R4/R4'彼此独立地为氢、较低烷基或CF3;或者是其对应的药学上可接受的酸盐、消旋混合物,或其相应的对映体和/或光学异构体和/或立体异构体。令人惊讶地发现,一般公式I化合物是代谢型谷酸受体亚型5(mGluR5)的正向变构调节剂(PAM)。
  • [EN] BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR<br/>[FR] DÉRIVÉ DE BENZÈNE OU DE THIOPHÈNE ET SON UTILISATION EN TANT QU'INHIBITEUR DE LA VAP-1
    申请人:R TECH UENO LTD
    公开号:WO2009145360A1
    公开(公告)日:2009-12-03
    The present invention provides a novel benzene derivative or thiophene derivative useful as a VAP-1 inhibitor, or a medicament for the prophylaxis or treatment of a VAP-1 associated disease and the like, namely, a compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a pharmaceutically acceptable salt thereof.
    本发明提供了一种新颖的苯衍生物噻吩生物,可用作VAP-1抑制剂,或用作预防或治疗与VAP-1相关的疾病等的药物,即由以下式(I)表示的化合物:其中每个符号如本说明书中所定义,或其药学上可接受的盐。
  • Palladium-catalyzed difluoromethylation of heteroaryl chlorides, bromides and iodides
    作者:Changhui Lu、Yang Gu、Jiang Wu、Yucheng Gu、Qilong Shen
    DOI:10.1039/c7sc00691h
    日期:——
    A palladium-catalyzed difluoromethylation of a series of heteroaryl chlorides, bromides and iodides under mild conditions is described. A wide range of heteroaryl halides such as pyridyl, pyrimidyl, pyrazyl, funanyl, thienyl, pyazolyl, imidazolyl, thiazolyl, and oxazolyl halides were efficiently difluoromethylated, thus providing medicinal chemists an alternative choice for the preparation of drug
    描述了在温和条件下一系列杂芳基化物,化物和化物的催化的二甲基化。各种杂芳基卤化物(例如吡啶基,嘧啶基,吡唑基,呋喃基,噻吩基,吡唑基,咪唑基,噻唑基和恶唑基卤化物)被有效地二甲基化,因此为药物化学家提供了制备具有二甲基化杂芳基单元的候选药物的替代选择。
查看更多

同类化合物

(乙腈)二氯镍(II) (R)-(-)-α-甲基组胺二氢溴化物 (N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-3-氨基环丁烷甲腈盐酸盐 顺式-2-羟基甲基-1-甲基-1-环己胺 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺二盐酸盐 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷